 |
인쇄하기
취소
|
GMP to review 172 drug companies without advanced notification.
The KFDA announced to review the GMP for 172 drug companies who were rated at an ordinary grade or lower starting from March 17, especially focusing on their facilities and quality controls.
The rating review was determined without any prior notification to them unlike the KFDA's conventional inspection, which gave a shrewd attention to those drug makers.
Based on the review outcomes for ...
The rating review was determined without any prior notification to them unlike the KFDA's conventional inspection, which gave a shrewd attention to those drug makers.
Based on the review outcomes for ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.